انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
3/30/2022 - COVID-19 BA.2 Subvariant & Boosters
Manage episode 324232432 series 2065653
Dr. Paul Auwaerter discusses the BA.2 Subvariant and the recent authorization from the FDA for second booster dose. Topics: *Virulence of BA.2 vs Omicron and Delta * Therapeutic activity of monoclonal antibodies against BA.2 *Details of approval for booster #2 (4th and 5th dose) *Are there advantages to mixing mRNA vaccines?
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-30-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine
Hosted on Acast. See acast.com/privacy for more information.
215 حلقات
Manage episode 324232432 series 2065653
Dr. Paul Auwaerter discusses the BA.2 Subvariant and the recent authorization from the FDA for second booster dose. Topics: *Virulence of BA.2 vs Omicron and Delta * Therapeutic activity of monoclonal antibodies against BA.2 *Details of approval for booster #2 (4th and 5th dose) *Are there advantages to mixing mRNA vaccines?
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-30-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine
Hosted on Acast. See acast.com/privacy for more information.
215 حلقات
Minden epizód
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.